Literature DB >> 17198273

Isolation of regulatory T cells in the skin of a human hand-allograft, up to six years posttransplantation.

Assia Eljaafari1, Lionel Badet, Jean Kanitakis, Christophe Ferrand, Annie Farre, Palmina Petruzzo, Emmanuel Morelon, Muriel Dubosson, Pierre Tiberghien, Valérie Dubois, Xavier Martin, Pierre Miossec, Jean-Michel Dubernard.   

Abstract

BACKGROUND: A bilateral hand allotransplantation was performed in a patient six years ago. Whereas skin is known to be highly immunogenic, grafts have been well accepted up to now. Therefore, here we investigated the putative presence of regulatory T cells in the graft.
METHODS: Skin biopsies were performed at different time points and analyzed by immunochemistry. T cells were initially expanded with interleukin (IL)-2. In the latter biopsy, skin was directly analyzed by reverse-transcriptase polymerase chain reaction without any culture.
RESULTS: When tested against donor mononuclear cells, donor-primed skin T cells demonstrated unresponsiveness and inhibited donor-directed blood T cell alloresponse. Moreover, their T-cell receptor-Vbeta repertoire was skewed, in contrast to that of peripheral blood T cells. Retrospectively, nuclear FoxP3 expression in skin was measured by immunohistochemistry and was found positive at that time, but appeared to increase with time. This result was supported by the measurement of FoxP3 messenger RNA (mRNA) expression in the latter fresh biopsy, which showed higher levels than that of blood, together with no expression of perforin mRNA, but increased expression of transforming growth factor-beta and IL-10. No FoxP3 mRNA expression was found in the contralateral leg, due to the absence of T cell infiltrate.
CONCLUSION: This study shows the presence of the FoxP3 marker, in a well accepted human composite tissue allograft, up to six years posttransplantation. Because a suppressive cytokinic profile was also detected intragraft, in the absence of perforin mRNA expression, our data suggest that regulatory T cells could play a role in the long-term survival of this allograft.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17198273     DOI: 10.1097/01.tp.0000250937.46187.ca

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  16 in total

1.  Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning.

Authors:  Jeng-Yee Lin; Feng-Chou Tsai; Christopher Glenn Wallace; Wei-Chao Huang; Fu-Chan Wei; Shuen-Kuei Liao
Journal:  Chimerism       Date:  2013 Jan-Mar

Review 2.  Composite tissue transplantation: a rapidly advancing field.

Authors:  K V Ravindra; S Wu; L Bozulic; H Xu; W C Breidenbach; S T Ildstad
Journal:  Transplant Proc       Date:  2008-06       Impact factor: 1.066

3.  Vascularized composite allograft tolerance across MHC barriers in a large animal model.

Authors:  D A Leonard; J M Kurtz; C Mallard; A Albritton; R Duran-Struuck; E A Farkash; R Crepeau; A Matar; B M Horner; M A Randolph; D H Sachs; C A Huang; C L Cetrulo
Journal:  Am J Transplant       Date:  2014-01-09       Impact factor: 8.086

4.  Vascularized composite allotransplantation combined with costimulation blockade induces mixed chimerism and reveals intrinsic tolerogenic potential.

Authors:  Byoung Chol Oh; Georg J Furtmüller; Madeline L Fryer; Yinan Guo; Franka Messner; Johanna Krapf; Stefan Schneeberger; Damon S Cooney; W P Andrew Lee; Giorgio Raimondi; Gerald Brandacher
Journal:  JCI Insight       Date:  2020-04-09

Review 5.  T regulatory cells and transplantation tolerance.

Authors:  Vijay S Gorantla; Stefan Schneeberger; Gerald Brandacher; Robert Sucher; Dong Zhang; W P Andrew Lee; Xin Xiao Zheng
Journal:  Transplant Rev (Orlando)       Date:  2010-06-11       Impact factor: 3.943

6.  Tolerance to vascularized composite allografts in canine mixed hematopoietic chimeras.

Authors:  David W Mathes; Billanna Hwang; Scott S Graves; James Edwards; Jeff Chang; Barry E Storer; Tiffany Butts-Miwongtum; George E Sale; Richard A Nash; Rainer Storb
Journal:  Transplantation       Date:  2011-12-27       Impact factor: 4.939

7.  Evidence that FoxP3+ regulatory T cells may play a role in promoting long-term acceptance of composite tissue allotransplants.

Authors:  Larry D Bozulic; Yujie Wen; Hong Xu; Suzanne T Ildstad
Journal:  Transplantation       Date:  2011-04-27       Impact factor: 4.939

Review 8.  Science of composite tissue allotransplantation.

Authors:  Bruce Swearingen; Kadiyala Ravindra; Hong Xu; Shengli Wu; Warren C Breidenbach; Suzanne T Ildstad
Journal:  Transplantation       Date:  2008-09-15       Impact factor: 4.939

9.  Composite tissue allotransplantation: past, present and future-the history and expanding applications of CTA as a new frontier in transplantation.

Authors:  S Wu; H Xu; K Ravindra; S T Ildstad
Journal:  Transplant Proc       Date:  2009-03       Impact factor: 1.066

Review 10.  Regulatory T cell induction, migration, and function in transplantation.

Authors:  Bryna E Burrell; Yumi Nakayama; Jiangnan Xu; C Colin Brinkman; Jonathan S Bromberg
Journal:  J Immunol       Date:  2012-11-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.